Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
Hui DuanHuimin LiShan KangHongwei ZhaoBiliang ChenLi WangPengfei LiYahong WangWei WangJinghe LangPing LiuChunlin ChenPublished in: Acta obstetricia et gynecologica Scandinavica (2023)
In terms of oncology outcomes of the study, FIGO 2018 Stage IIIC of cervical cancer is unreasonable. Stages IIIC-T1, T2a, and T2b may be integrated as IIC, and it might be unnecessary for T3a/T3b cases to be subdivided by lymph node status.